These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 21566447)

  • 1. [A case of imatinib-resistant GIST treated by sunitinib].
    Sakamoto Y; Akimoto H; Kojo M; Kawano H; Chinen Y; Morita K; Sugiyama M; Saeki H; Minami K; Soejima Y; Sakaguchi Y; Toh Y; Okamura T
    Gan To Kagaku Ryoho; 2011 May; 38(5):827-30. PubMed ID: 21566447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sunitinib for imatinib-resistant GIST.
    Joensuu H
    Lancet; 2006 Oct; 368(9544):1303-4. PubMed ID: 17046443
    [No Abstract]   [Full Text] [Related]  

  • 3. Surgical resection of residual disease in initially inoperable imatinib-resistant/intolerant gastrointestinal stromal tumor treated with sunitinib.
    Ruka W; Rutkowski P; Szawłowski A; Nowecki Z; Debiec-Rychter M; Grzesiakowska U; Dziewirski W; Siedlecki JA; Michej W
    Eur J Surg Oncol; 2009 Jan; 35(1):87-91. PubMed ID: 18289826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of gastrointestinal stromal tumor (GIST) successfully treated with resection after a long-term control medication by molecular targeted drugs].
    Inoue Y; Yoshino S; Suzuki N; Hazama S; Oka M
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2378-80. PubMed ID: 22202388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of recurrent duodenal gastrointestinal stromal tumor resistant to imatinib and sunitinib, successfully treated with regorafenib].
    Takeda Y; Nakahira S; Katsura Y; Ohmura Y; Kusama H; Kuroda Y; Goto T; Hashimoto T; Kimura K; Matsushita K; Sato Y; Morimoto Y; Ishida T; Nitta K; Kagawa Y; Okishiro M; Takeno A; Sakisaka H; Taniguchi H; Egawa C; Ohzono K; Nakatsuka S; Kato T; Tamura S
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1545-7. PubMed ID: 25731247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical intervention for imatinib and sunitinib-resistant gastrointestinal stromal tumors.
    Kikuchi H; Setoguchi T; Miyazaki S; Yamamoto M; Ohta M; Kamiya K; Sakaguchi T; Konno H
    Int J Clin Oncol; 2011 Dec; 16(6):741-5. PubMed ID: 21394667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of imatinib-resistant gastrointestinal stromal tumor treated with low-dose sunitinib].
    Yoshida Y; Akahoshi S; Kiyota Y; Motooka Y; Kiyozumi Y; Yamaguchi R; Inoue K
    Gan To Kagaku Ryoho; 2013 Dec; 40(13):2573-5. PubMed ID: 24335373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant use of sunitinib in locally advanced GIST with intolerance to imatinib.
    Svetlichnaya J; Huyck TK; Wayne JD; Agulnik M
    Chemotherapy; 2012; 58(1):30-3. PubMed ID: 22415035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in therapy for gastrointestinal stromal tumors.
    Maki RG
    Curr Oncol Rep; 2007 May; 9(3):165-9. PubMed ID: 17430686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Approval summary: sunitinib for the treatment of imatinib refractory or intolerant gastrointestinal stromal tumors and advanced renal cell carcinoma.
    Goodman VL; Rock EP; Dagher R; Ramchandani RP; Abraham S; Gobburu JV; Booth BP; Verbois SL; Morse DE; Liang CY; Chidambaram N; Jiang JX; Tang S; Mahjoob K; Justice R; Pazdur R
    Clin Cancer Res; 2007 Mar; 13(5):1367-73. PubMed ID: 17332278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evidence-based treatment of gastrointestinal stromal tumor (GIST) with tyrosine kinase inhibitors-imatinib and sunitinib].
    Nishida T; Omori T; Ueshima S
    Gan To Kagaku Ryoho; 2011 May; 38(5):733-7. PubMed ID: 21566432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment with sunitinib in a young patient with metastatic gastrointestinal stromal tumor after failure on adjuvant imatinib.
    Kapoor R; Khosla D; Kumar P; Kumar N; Bera A
    J Cancer Res Ther; 2011; 7(4):491-3. PubMed ID: 22269418
    [No Abstract]   [Full Text] [Related]  

  • 13. Nilotinib is effective in imatinib and sunitinib resistant GIST: a case report.
    Dizdar O; Yalcin S
    Hepatogastroenterology; 2011; 58(107-108):859-60. PubMed ID: 21830404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of small intestinal gastrointestinal stromal tumor (GIST) with peritoneal dissemination, treated effectively with molecular target drug after operation].
    Hosaka S; Umemoto S; Kikutake T; Yonemitsu K; Nagao S; Kawamoto S; Yoshida T
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):2472-4. PubMed ID: 25731561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-kit, GIST, and imatinib.
    Siehl J; Thiel E
    Recent Results Cancer Res; 2007; 176():145-51. PubMed ID: 17607922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy and safety of sunitinib on patients with imatinib-resistant gastrointestinal stromal tumor].
    Liu X; Jiang WZ; Guan GX; Chen ZF; Chi P; Lu HS
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar; 16(3):221-5. PubMed ID: 23536339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal stromal tumors: imatinib and beyond.
    Schnadig ID; Blanke CD
    Curr Treat Options Oncol; 2006 Nov; 7(6):427-37. PubMed ID: 17032555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of nilotinib (AMN-107) alone in advanced gastrointestinal stromal tumors progressing on imatinib and sunitinib. Case report.
    Sevinc A
    Chemotherapy; 2009; 55(2):132-6. PubMed ID: 19188713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term exposure of gastrointestinal stromal tumor cells to sunitinib induces epigenetic silencing of the PTEN gene.
    Yang J; Ikezoe T; Nishioka C; Takezaki Y; Hanazaki K; Taguchi T; Yokoyama A
    Int J Cancer; 2012 Feb; 130(4):959-66. PubMed ID: 21445973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Two cases of recurrent GIST successfully treated with imatinib mesylate at 100mg/day].
    Hanada N; Kawata K; Okamura S; Tomiyama N; Hori K
    Gan To Kagaku Ryoho; 2013 Jun; 40(6):803-5. PubMed ID: 23863663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.